Head-to-head · WeighScore
EmbraceRX vs SnagRx
The verdict
EmbraceRX takes it — 58.6/100 to 57.9/100, but only just.
EmbraceRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EmbraceRX (Embrace Rx) is a clinician-guided telehealth platform offering pharmacy-compounded medications prescribed online, partnered with the Samaritan MD physician network. SnagRx is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EmbraceRX | SnagRx |
|---|---|---|
| WeighScore | 58.6/100 | 57.9/100 |
| Grade | C | C |
| Scorecard rank | #363 | #387 |
| Semaglutide | Not disclosed | $299/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $399/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #363 · C
Strengths
- Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
- Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
- Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
- Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)
Where it loses points
- Pricing not shown upfront — revealed only at checkout after a dose selection
- Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
- Compounding pharmacy partner not named ('FDA-registered pharmacies')
- Not LegitScript-certified (no certification displayed)
Graded #387 · C
Strengths
- Compounded semaglutide ($99/mo) and tirzepatide ($149/mo) on launch discount, flat-priced at every dose
- Names four partner pharmacies in Terms (RedRock, Health Warehouse, Precision Compounding, Triad Rx)
- Available in all 50 states plus Washington D.C. per Terms
- Telemed visit, prescription and free 1-2 day shipping included; no insurance or membership
- Cancel anytime; full refund if disqualified by the medical provider
Where it loses points
- Headline $99/$149 prices are discounted from $299/$399 standard; a countdown timer pressures signup
- No brand-name Wegovy/Zepbound/Mounjaro/Ozempic - compounded injectable only
- Refunds only available before medication is ordered; all sales otherwise final
- Binding JAMS arbitration under Delaware law; class-action waiver
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.